How much is Reference Medicine worth in 2026?

Reference Medicine has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Reference Medicine raised?

Reference Medicine has raised N/A in total funding across 1 funding rounds.

Reference Medicine

Other Pharmaceuticals and Biotechnology

Reference Medicine valuation and funding history | Last updated: August 16, 2021 | 1 funding rounds

Current Valuation

N/A

As of August 16, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

$3.0M

Last Funding

Aug 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 16, 2021	Seed Round	$3.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Reference Medicine is currently valued at N/A as of August 16, 2021.

Track Reference Medicine Valuation Updates

Get notified when Reference Medicine raises new funding or valuation changes

Explore More Data

Detailed analysis for Reference Medicine

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Reference Medicine's valuation history, funding rounds, and growth metrics.

No credit card required

What is Reference Medicine Worth in 2026?

Reference Medicine is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Reference Medicine's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Reference Medicine Valuation is Determined

Private company valuations like Reference Medicine's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.